Institute for Wealth Management’s TG Therapeutics TGTX Stock Holding History

Institute for Wealth Management’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.13K	Buy	+57	New	+$2.33K	﹤0.01%	1526

Other funds holding TGTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Institute for Wealth Management's TGTX Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in TG Therapeutics (TGTX) in Q2 2026: 57 shares worth $3.13K. The stake represents ﹤0.01% of the portfolio and ranks #1526 among its holdings.

204 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

Institute for Wealth Management held 57 shares of TG Therapeutics worth $3.13K as of Q2 2026.
TG Therapeutics was a new Institute for Wealth Management position in Q2 2026.
TG Therapeutics made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1526 holding.
204 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.